Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 158

1.

A Fungal Immunotherapeutic Vaccine (NDV-3A) for Treatment of Recurrent Vulvovaginal Candidiasis-A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial.

Edwards JE Jr, Schwartz MM, Schmidt CS, Sobel JD, Nyirjesy P, Schodel F, Marchus E, Lizakowski M, DeMontigny EA, Hoeg J, Holmberg T, Cooke MT, Hoover K, Edwards L, Jacobs M, Sussman S, Augenbraun M, Drusano M, Yeaman MR, Ibrahim AS, Filler SG, Hennessey JP Jr.

Clin Infect Dis. 2018 Jun 1;66(12):1928-1936. doi: 10.1093/cid/ciy185.

PMID:
29697768
2.

Lupus-like membranous nephropathy: Is it lupus or not?

Sam R, Joshi A, James S, Jen KY, Amani F, Hart P, Schwartz MM.

Clin Exp Nephrol. 2015 Jun;19(3):395-402. doi: 10.1007/s10157-014-1002-1. Epub 2014 Jul 4.

PMID:
24993947
3.

Capping ligands as selectivity switchers in hydrogenation reactions.

Kwon SG, Krylova G, Sumer A, Schwartz MM, Bunel EE, Marshall CL, Chattopadhyay S, Lee B, Jellinek J, Shevchenko EV.

Nano Lett. 2012 Oct 10;12(10):5382-8. doi: 10.1021/nl3027636. Epub 2012 Sep 25.

PMID:
22988832
4.

Autocrine CSF-1 and CSF-1 receptor coexpression promotes renal cell carcinoma growth.

Menke J, Kriegsmann J, Schimanski CC, Schwartz MM, Schwarting A, Kelley VR.

Cancer Res. 2012 Jan 1;72(1):187-200. doi: 10.1158/0008-5472.CAN-11-1232. Epub 2011 Nov 3.

5.

The Oxford classification of IgA nephropathy: a retrospective analysis.

Yau T, Korbet SM, Schwartz MM, Cimbaluk DJ.

Am J Nephrol. 2011;34(5):435-44. doi: 10.1159/000332223. Epub 2011 Sep 28.

PMID:
21968096
6.

Circulating CSF-1 promotes monocyte and macrophage phenotypes that enhance lupus nephritis.

Menke J, Rabacal WA, Byrne KT, Iwata Y, Schwartz MM, Stanley ER, Schwarting A, Kelley VR.

J Am Soc Nephrol. 2009 Dec;20(12):2581-92. doi: 10.1681/ASN.2009050499. Epub 2009 Nov 19.

7.

Pathogenetic features of severe segmental lupus nephritis.

Behara VY, Whittier WL, Korbet SM, Schwartz MM, Martens M, Lewis EJ.

Nephrol Dial Transplant. 2010 Jan;25(1):153-9. doi: 10.1093/ndt/gfp424. Epub 2009 Aug 23.

PMID:
19703837
8.

Evidence of concurrent immunopathological mechanisms determining the pathology of severe lupus nephritis.

Schwartz MM, Korbet SM, Katz RS, Lewis EJ.

Lupus. 2009 Feb;18(2):149-58. doi: 10.1177/0961203308095947.

PMID:
19151117
9.

Predictors of success on national council licensure examination for registered nurses for accelerated baccalaureate nursing graduates.

Abbott AA, Schwartz MM, Hercinger M, Miller CL, Foyt ME.

Comput Inform Nurs. 2008 Sep-Oct;26(5 Suppl):96S-97S. doi: 10.1097/01.NCN.0000336453.62659.06. No abstract available.

PMID:
18791401
10.

Intravascular hemolysis and acute renal failure after mitral and aortic valve repair.

Concepcion B, Korbet SM, Schwartz MM.

Am J Kidney Dis. 2008 Nov;52(5):1010-5. doi: 10.1053/j.ajkd.2008.03.021. Epub 2008 May 29. No abstract available.

PMID:
18511167
11.

Predictors of success on National Council Licensure examination for registered nurses for accelerated baccalaureate nursing graduates.

Abbott AA, Schwartz MM, Hercinger M, Miller CL, Foyt ME.

Nurse Educ. 2008 Jan-Feb;33(1):5-6. No abstract available.

PMID:
18091462
12.

APOE Kyoto mutation in European Americans with lipoprotein glomerulopathy.

Rovin BH, Roncone D, McKinley A, Nadasdy T, Korbet SM, Schwartz MM.

N Engl J Med. 2007 Dec 13;357(24):2522-4. No abstract available.

13.

The prognosis and pathogenesis of severe lupus glomerulonephritis.

Schwartz MM, Korbet SM, Lewis EJ; Collaborative Study Group.

Nephrol Dial Transplant. 2008 Apr;23(4):1298-306. Epub 2007 Nov 28.

PMID:
18045825
14.

Value of a complete or partial remission in severe lupus nephritis.

Chen YE, Korbet SM, Katz RS, Schwartz MM, Lewis EJ; Collaborative Study Group.

Clin J Am Soc Nephrol. 2008 Jan;3(1):46-53. Epub 2007 Nov 14.

15.

Immuotactoid glomerulopathy (fibrillary glomerulonephritis).

Korbet SM, Schwartz MM, Lewis EJ.

Clin J Am Soc Nephrol. 2006 Nov;1(6):1351-6. Epub 2006 Sep 13. No abstract available.

16.

The pathology of lupus nephritis.

Schwartz MM.

Semin Nephrol. 2007 Jan;27(1):22-34. Review.

PMID:
17336686
17.

Idiopathic hypocomplementemic immune-complex-mediated tubulointerstitial nephritis.

Vaseemuddin M, Schwartz MM, Dunea G, Kraus MA.

Nat Clin Pract Nephrol. 2007 Jan;3(1):50-8.

PMID:
17183262
18.

Severe lupus nephritis: racial differences in presentation and outcome.

Korbet SM, Schwartz MM, Evans J, Lewis EJ; Collaborative Study Group.

J Am Soc Nephrol. 2007 Jan;18(1):244-54. Epub 2006 Dec 13.

19.

Multiple myeloma.

Korbet SM, Schwartz MM.

J Am Soc Nephrol. 2006 Sep;17(9):2533-45. Epub 2006 Aug 2. Review. No abstract available.

20.
21.

Lipoprotein glomerulopathy: a new apolipoprotein E mutation with enhanced glomerular binding.

Sam R, Wu H, Yue L, Mazzone T, Schwartz MM, Arruda JA, Dunea G, Singh AK.

Am J Kidney Dis. 2006 Mar;47(3):539-48. Review.

PMID:
16490634
22.

The blind men and the elephant.

Schwartz MM.

Kidney Int. 2005 Oct;68(4):1894-5. No abstract available.

23.

Heparanase-1 gene expression and regulation by high glucose in renal epithelial cells: a potential role in the pathogenesis of proteinuria in diabetic patients.

Maxhimer JB, Somenek M, Rao G, Pesce CE, Baldwin D Jr, Gattuso P, Schwartz MM, Lewis EJ, Prinz RA, Xu X.

Diabetes. 2005 Jul;54(7):2172-8.

24.

Pulmonary-renal syndrome in a newborn with placental transmission of ANCAs.

Schlieben DJ, Korbet SM, Kimura RE, Schwartz MM, Lewis EJ.

Am J Kidney Dis. 2005 Apr;45(4):758-61. Erratum in: Am J Kidney Dis. 2005 Jul;46(1):171.

PMID:
15806479
25.

Pathology of lupus nephritis.

Lewis EJ, Schwartz MM.

Lupus. 2005;14(1):31-8. Review.

PMID:
15732285
26.

Glomerular podocytopathy in patients with systemic lupus erythematosus.

Kraft SW, Schwartz MM, Korbet SM, Lewis EJ.

J Am Soc Nephrol. 2005 Jan;16(1):175-9. Epub 2004 Nov 17.

27.
28.

The classification of glomerulonephritis in systemic lupus erythematosus revisited.

Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi LM, Makino H, Moura LA, Nagata M.

J Am Soc Nephrol. 2004 Feb;15(2):241-50. Erratum in: J Am Soc Nephrol. 2004 Mar;15(3):835-6.

29.

The classification of glomerulonephritis in systemic lupus erythematosus revisited.

Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi LM, Makino H, Moura LA, Nagata M; International Society of Nephrology Working Group on the Classification of Lupus Nephritis; Renal Pathology Society Working Group on the Classification of Lupus Nephritis.

Kidney Int. 2004 Feb;65(2):521-30. Review. Erratum in: Kidney Int. 2004 Mar;65(3):1132.

30.

The frequency of thrombotic thrombocytopenic purpura in patients with systemic lupus erythematosus undergoing kidney biopsy.

Manadan AM, Harris C, Schwartz MM, Block JA.

J Rheumatol. 2003 Jun;30(6):1227-30.

PMID:
12784394
31.

Rewriting the histological classification of lupus nephritis.

Schwartz MM, Lewis EJ.

J Nephrol. 2002 Nov-Dec;15 Suppl 6:S11-9. Review.

PMID:
12515369
32.

Immunotactoid glomerulopathy.

Schwartz MM, Korbet SM, Lewis EJ.

J Am Soc Nephrol. 2002 May;13(5):1390-7. Review. No abstract available.

33.

Severe lupus nephritis: importance of re-evaluating the histologic classification and the approach to patient care.

Lewis EJ, Schwartz MM, Korbet SM.

J Nephrol. 2001 Jul-Aug;14(4):223-7. Review.

PMID:
11506244
34.

Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis.

Najafi CC, Korbet SM, Lewis EJ, Schwartz MM, Reichlin M, Evans J; Lupus Nephritis Collaborative Study Group.

Kidney Int. 2001 Jun;59(6):2156-63.

35.

The role of podocyte injury in the pathogenesis of focal segmental glomerulosclerosis.

Schwartz MM.

Ren Fail. 2000 Nov;22(6):663-84. Review.

PMID:
11104157
36.

The Holy Grail: pathological indices in lupus nephritis.

Schwartz MM.

Kidney Int. 2000 Sep;58(3):1354-5. No abstract available.

37.

Factors predictive of outcome in severe lupus nephritis. Lupus Nephritis Collaborative Study Group.

Korbet SM, Lewis EJ, Schwartz MM, Reichlin M, Evans J, Rohde RD.

Am J Kidney Dis. 2000 May;35(5):904-14.

PMID:
10793026
38.

Focal segmental glomerulosclerosis: prognostic implications of the cellular lesion.

Schwartz MM, Evans J, Bain R, Korbet SM.

J Am Soc Nephrol. 1999 Sep;10(9):1900-7.

39.

Renal pathology patterns in type II diabetes mellitus: relationship with retinopathy. The Collaborative Study Group.

Schwartz MM, Lewis EJ, Leonard-Martin T, Lewis JB, Batlle D.

Nephrol Dial Transplant. 1998 Oct;13(10):2547-52.

PMID:
9794557
40.

Juvenile rheumatoid arthritis in African Americans.

Schwartz MM, Simpson P, Kerr KL, Jarvis JN.

J Rheumatol. 1997 Sep;24(9):1826-9.

PMID:
9292811
41.

The racial prevalence of glomerular lesions in nephrotic adults.

Korbet SM, Genchi RM, Borok RZ, Schwartz MM.

Am J Kidney Dis. 1996 May;27(5):647-51.

PMID:
8629623
42.
43.

Renal vasculitis associated with ciprofloxacin.

Shih DJ, Korbet SM, Rydel JJ, Schwartz MM.

Am J Kidney Dis. 1995 Sep;26(3):516-9.

PMID:
7645562
44.

Primary focal segmental glomerular sclerosis in adults: prognostic value of histologic variants.

Schwartz MM, Korbet SM, Rydell J, Borok R, Genchi R.

Am J Kidney Dis. 1995 Jun;25(6):845-52.

PMID:
7771480
45.

Palpable purpura and acute oliguric glomerulonephritis in an adult.

Saltzberg SN, Schwartz MM.

Am J Kidney Dis. 1995 Apr;25(4):651-9. No abstract available.

PMID:
7702067
46.

Focal segmental glomerular sclerosis in adults: presentation, course, and response to treatment.

Rydel JJ, Korbet SM, Borok RZ, Schwartz MM.

Am J Kidney Dis. 1995 Apr;25(4):534-42.

PMID:
7702047
47.

Lupus nephritis.

Schwartz MM.

Curr Opin Nephrol Hypertens. 1995 Mar;4(2):162-8. Review.

PMID:
7600047
48.

Nephrotic syndrome in a patient with unilateral renal dysplasia.

Rodby RA, Schwartz MM.

Am J Kidney Dis. 1995 Jan;25(1):88-95. Review. No abstract available.

PMID:
7810541
49.

The mesangium in the long-term remnant kidney model.

Schwartz MM, Evans J, Bidani AK.

J Lab Clin Med. 1994 Nov;124(5):644-51.

PMID:
7964122
50.

Renal ablation acutely transforms 'benign' hypertension to 'malignant' nephrosclerosis in hypertensive rats.

Bidani AK, Griffin KA, Plott W, Schwartz MM.

Hypertension. 1994 Sep;24(3):309-16.

PMID:
8082937

Supplemental Content

Loading ...
Support Center